by stemcellclub | Oct 23, 2026 | Stem Cell Therapy
Research Spotlight · Aging & Frailty Can a stem cell infusion help frail older adults walk farther? A 148-person placebo-controlled trial, published in Cell Stem Cell in 2026, is the strongest attempt yet to find out. The results are interesting. They are also...
by stemcellclub | Oct 21, 2026 | Stem Cell Therapy
Research Spotlight · Multiple Sclerosis A stem cell transplant for multiple sclerosis is no longer a fringe idea. It has a randomized trial behind it, European treatment recommendations, and three more randomized trials racing toward results. It is also chemotherapy,...
by stemcellclub | Oct 19, 2026 | Stem Cell Therapy
Research Spotlight · Clinical Trial A stem cell–derived dopamine neuron therapy for Parkinson’s is now in a Phase 3 trial with a sham-surgery control group. Four-year Phase 1 data were just presented in October 2026. Here is what the early numbers show, why the...
by stemcellclub | Oct 16, 2026 | Stem Cell Therapy
Research Spotlight · Clinical Trial A heart-derived cell therapy for Duchenne muscular dystrophy just got published in The Lancet and is sitting at the FDA with a November 2026 decision date. The company says the Phase 3 trial worked. The FDA’s own briefing says...
by stemcellclub | Oct 14, 2026 | Stem Cell Injections, Stem Cell Therapy
Research Spotlight · Clinical Trial A Korean stem cell product that has been sold since 2012 just started its U.S. pivotal trial. It is a surgery, not a shot. It uses cord blood cells, not cord tissue. And it is not approved here. Here is what CARTISTEM is, what the...
by stemcellclub | Oct 12, 2026 | Stem Cell Therapy
Research Spotlight · FDA Approval In December 2024 the FDA approved the first mesenchymal stromal cell therapy in the United States. That is a real milestone. It is also narrower, and more specific, than most headlines make it sound. Here is what Ryoncil actually is,...